Skip to content

Impact of a Hospital Physical Therapy Program on Chronic Obstructive Pulmonary Disease (COPD) Patients

Impact of a Hospital Physical Therapy Program on Exacerbated Chronic Obstructive Pulmonary Disease Patients: A Randomized Controlled Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01295359
Enrollment
40
Registered
2011-02-14
Start date
2011-03-31
Completion date
2012-08-31
Last updated
2011-03-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Obstructive Pulmonary Disease

Keywords

Chronic Obstructive Pulmonary Disease, Walking, Hospital, Exercise Tolerance, Physical Therapy

Brief summary

The Chronic Obstructive Pulmonary Disease is a leading global cause of morbidity and mortality, so it's important to find actions that could improve quality of life and decrease the mortality. The objective of this study is to verify if a ground walking program applied to hospitalized exacerbated COPD patients has effects in quality of life, exercise capacity, airways obstruction, body composition, heart rate variability, quadriceps isometric force and in the Body-mass index, Airway Obstruction, Dyspnea, Exercise Capacity index (BODE index). An evaluators-blinded randomized controlled study will be conducted in Hospital Escola Municipal de São Carlos where forty patients will be recruited to participate. The volunteers will be randomized in two groups with twenty patients, the usual care group, that will receive only the usual care of the hospital; and the trained group that will receive the same care, but will also participate in a ground walking program associated with respiratory exercises. It will be evaluated, in the start and at the end of the program, the health related and general quality of life and the Barthel index. Daily, the patient will be submitted to the Six Minute Walk Test, to a body composition analysis, to a hand grip test and to a dyspnea assessment, and will be calculated its BODE index. All patients will be invited to a follow up in the 12th and 24th weeks after hospital discharge, when they would receive the same evaluation of the last day in the hospital. All the collected data will be expressed in means and standard deviations or medians and range when appropriated. It will be chosen appropriated tests to compare and correlate them.

Interventions

OTHERGround Walking Program

The patients will walk on a corridor, for 40min, once a day. The speed will be controlled through a metronome, that will be programed to a frequency of steps/min determinated as 80% of the mean frequency of steps performed in six minutes walk test of that day. The 40min will be divided in 3min of walk and 2min of rest, totalizing 24min of exercise and 16min of rest. Furthermore, these patients, in sitting position, will receive orientation to do calm and slow inspirations and expirations, associated with pursed lips expiration. They will try to maintain its Respiratory Rate in 6bpm, during four minutes.

Sponsors

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.
CollaboratorOTHER_GOV
Universidade Federal de Sao Carlos
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
50 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* COPD Patients (FEV1/FVC \< 0,70; FEV1 \> 30% and \< 80%) * Hospitalized for exacerbation of COPD

Exclusion criteria

* Conditions that could restrict walking * Skeletal-muscle and joint disturbs * Extreme Obesity (BMI \> 35kg/m²) * Heart Failure (New York Heart Association class III and IV) * Uncontrolled infection (fever \> 38ºC and leukocytosis \> 10000 cels/dl) * Need of Invasive Mechanical Ventilation after the beginning of the program * Previous Diagnosis of: * Stroke * Epilepsy * Coagulation disorders (INR \> 1,5 or platelets \< 50.000/m³) * Psychiatric Disorders or severe agitation * Cardiac or respiratory instability * Oxygen therapy \> 3L/min at rest * Respiratory Rate \> 30 breaths/min at rest * Tachycardia and Bradycardia * Vasoactive Drugs need

Design outcomes

Primary

MeasureTime frameDescription
Change in Exercise CapacityDaily, as soon as medically appropriated, during the hospitalizationIt will be evaluated through the six minutes walking distance, performed according to ATS rules.
Change in BODE indexDaily, as soon as medically appropriated, during the hospitalizationThe Body-Mass Index, Airways Obstruction, Dyspnea, Exercise Capacity (BODE) index. This is a multidimensional evaluation that includes Forced Expiratory Volume in the first second, Body-Mass Index, 6 Minutes Walking Distance and mMRC score. It is an index to predict mortality.

Secondary

MeasureTime frameDescription
Change in Perceived discomfort in lower limbsDaily, as soon as medically appropriated, during the hospitalizationEvaluated during the six minutes walk test through the BORG CR10 scale
Change in Variation in Heart RateDaily, as soon as medically appropriated, during the hospitalizationIt will be evaluated the variation in the Heart Rate during the six minutes walk test (Exercise Peak - rest)
Change in the need of oxygen therapyDaily, as soon as medically appropriated, during the hospitalizationWill be evaluated the need of oxygen therapy during the six minutes walk test
Change in Handgrip Isometric ForceDaily, as soon as medically appropriated, during the hospitalizationIt will be evaluated through a hand grip dynamometer.
Change in Body CompositionDaily, as soon as medically appropriated, during the hospitalizationIt will be performed through a body composition monitor, evaluating weight, body Fat percentage, Muscle Mass, Basal Metabolic Rate, Bone Mass and Total Body Water Percentage.
Change in General Quality of Lifefirst day of the protocol and at the day of dischargeIt will be evaluated through the SF-36 questionnaire
Days in hospitalAt the discharge
Change in Reported DyspneaDaily, as soon as medically appropriated, during the hospitalizationIt will be evaluated through the Modified Medical Research Concil Questionnaire
Change in Heart Rate Variabilityfirst day of the protocol and at the day of dischargeIt will be recorded through a cardiac monitor, and analized in the time and frequency domain, and non-linear analysis.
Quadriceps Isometric Forcefirst day of the protocol and at the day of dischargeIt will be evaluated through a hand held dynamometer.
Change in Forced Expiratory Volume in the First SecondDaily, as soon as medically appropriated, during the hospitalizationIt will be evaluated through espirometry
Change in Perceived DyspneaDaily, as soon as medically appropriated, during the hospitalizationDyspnea during the six minutes walk test through the BORG CR10 scale

Countries

Brazil

Contacts

Primary ContactJuliano Ferreira Arcuri, Especialist
julianoarcuri@gmail.com+55 (16) 97838283
Backup ContactAdriana Sanches Garcia de Araujo, Masters
garciadrica@hotmail.com+55 (16) 81587480

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026